Q32 Bio Stock Analysis

QTTB Stock   2.19  0.13  5.60%   
Q32 Bio is overvalued with Real Value of 1.9 and Hype Value of 2.19. The main objective of Q32 Bio stock analysis is to determine its intrinsic value, which is an estimate of what Q32 Bio is worth, separate from its market price. There are two main types of Q32 Bio's stock analysis: fundamental analysis and technical analysis.
The Q32 Bio stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Q32 Bio's ongoing operational relationships across important fundamental and technical indicators.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Q32 Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For information on how to trade Q32 Stock refer to our How to Trade Q32 Stock guide.

Q32 Stock Analysis Notes

About 73.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 7.57. Q32 Bio had not issued any dividends in recent years. The entity had 1:18 split on the 26th of March 2024. To find out more about Q32 Bio contact Jodie Morrison at 781 999 0232 or learn more at https://www.q32bio.com.

Q32 Bio Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Q32 Bio's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Q32 Bio or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Q32 Bio is way too risky over 90 days horizon
Q32 Bio appears to be risky and price may revert if volatility continues
Q32 Bio has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (47.73 M) with loss before overhead, payroll, taxes, and interest of (48.25 M).
Q32 Bio generates negative cash flow from operations
About 73.0% of the company shares are owned by institutional investors

Q32 Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 26.77 M.

Technical Drivers

As of the 21st of July, Q32 Bio owns the coefficient of variation of 1618.44, and Market Risk Adjusted Performance of 1.69. In connection with fundamental indicators, the technical analysis model allows you to check timely technical drivers of Q32 Bio, as well as the relationship between them.

Q32 Bio Price Movement Analysis

The output start index for this execution was eleven with a total number of output elements of fifty. The Simple Moving Average indicator is calculated by adding the closing price of Q32 Bio for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Q32 Bio short-term fluctuations and highlight longer-term trends or cycles.

Q32 Bio Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Q32 Bio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Q32 Bio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Q32 Bio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Manke Isaac over a month ago
Acquisition by Manke Isaac of 12767 shares of Q32 Bio at 16.82 subject to Rule 16b-3
 
Tzianabos Arthur over two months ago
Acquisition by Tzianabos Arthur of 12767 shares of Q32 Bio at 2.54 subject to Rule 16b-3
 
Laporte Kathleen over three months ago
Acquisition by Laporte Kathleen of 5431 shares of Q32 Bio at 2.54 subject to Rule 16b-3
 
Lundberg Sven Ante over three months ago
Disposition of 12767 shares by Lundberg Sven Ante of Q32 Bio at 16.82 subject to Rule 16b-3
 
Shelia Violette over three months ago
Disposition of 13513 shares by Shelia Violette of Q32 Bio at 3.13 subject to Rule 16b-3
 
Shelia Violette over six months ago
Acquisition by Shelia Violette of 6000 shares of Q32 Bio at 7.29 subject to Rule 16b-3
 
Shelia Violette over six months ago
Disposition of 4361 shares by Shelia Violette of Q32 Bio at 3.12 subject to Rule 16b-3
 
Shelia Violette over six months ago
Disposition of 13300 shares by Shelia Violette of Q32 Bio at 3.12 subject to Rule 16b-3
 
Lundberg Sven Ante over six months ago
Acquisition by Lundberg Sven Ante of 1316 shares of Q32 Bio at 44.4 subject to Rule 16b-3
 
Lundberg Sven Ante over six months ago
Acquisition by Lundberg Sven Ante of 1316 shares of Q32 Bio at 44.4 subject to Rule 16b-3
 
Campagna Jason over six months ago
Acquisition by Campagna Jason of 70687 shares of Q32 Bio at 16.82 subject to Rule 16b-3
 
Violette Shelia M. over a year ago
Acquisition by Violette Shelia M. of 56413 shares of Q32 BIO at 16.82 subject to Rule 16b-3

Q32 Bio Outstanding Bonds

Q32 Bio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Q32 Bio uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Q32 bonds can be classified according to their maturity, which is the date when Q32 Bio has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Q32 Bio Predictive Daily Indicators

Q32 Bio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Q32 Bio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Q32 Bio Forecast Models

Q32 Bio's time-series forecasting models are one of many Q32 Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Q32 Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Q32 Bio to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Complementary Tools for Q32 Stock analysis

When running Q32 Bio's price analysis, check to measure Q32 Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Q32 Bio is operating at the current time. Most of Q32 Bio's value examination focuses on studying past and present price action to predict the probability of Q32 Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Q32 Bio's price. Additionally, you may evaluate how the addition of Q32 Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance